The Almac Group is an established contract development and manufacturing organization (CDMO) providing an extensive range of integrated services across the drug development lifecycle. From early-stage biomarker discovery and API manufacture to clinical trial supply and commercial-scale production, Almac delivers quality-driven solutions to global pharmaceutical and biotech partners.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.